thiazoles has been researched along with Experimental Mammary Neoplasms in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (35.71) | 18.7374 |
| 1990's | 4 (9.52) | 18.2507 |
| 2000's | 9 (21.43) | 29.6817 |
| 2010's | 11 (26.19) | 24.3611 |
| 2020's | 3 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, A; Huang, R; Liang, J; Tang, M; Wang, L; Zhou, J | 1 |
| Cai, Y; Gao, X; Shuai, Q; Sun, X; Xu, J; Xu, Z; Zhu, F | 1 |
| Chen, B; Chen, T; Duan, Y; Han, D; Li, C; Li, Y; Liang, Y; Liu, Y; Song, X; Wang, L; Wang, X; Yang, Q; Zhang, H; Zhang, N; Zhao, W | 1 |
| Bradshaw, C; Flecknell, P; Lee, CCS; Lofgren, J; Miller, AL; Roughan, J | 1 |
| Cheung, P; Kakit, C; Kiess, N; Parsons, R; Pegno, S; Poulikakos, PI; Schmidt, H; Stratikopoulos, EE; Szabolcs, M; Wu, X | 1 |
| Brunton, VG; Carragher, NO; Creedon, H; Evans, TR; Gusterson, B; Karim, SA; Morton, JP; Muller, WJ; Patel, H; Sansom, OJ | 1 |
| Fant, ME; Glazer, RI; Kallakury, B; Kopelovich, L; Lu, J; Umans, R; Upadhyay, G; Xiao, J; Yin, Y; Yuan, H | 1 |
| Bailey, ST; Clark, K; Damrauer, JS; Darr, D; Diehn, M; Fan, C; Hadzic, T; Jeong, Y; Jin, J; Kim, WY; Lee, CY; Levine, RL; Miller, CR; Murphy, L; Perou, CM; Troester, MA; Zhou, B | 1 |
| Beristain, AG; Chang, MC; Di Grappa, MA; Joshi, PA; Khokha, R; Kirschner, LS; Molyneux, SD; Pomroy, NC; Privé, GG; Pujana, MA | 1 |
| Aly, H; Attia, SM; Bahashwan, SA; El-Beshbishy, HA; Ghobara, MM; Hassan, MH | 1 |
| Krop, IE; Lin, NU; Liu, P; Roberts, TM; Spangle, JM; Von, T; Wang, Q; Winer, EP; Zhao, JJ | 1 |
| Bansal, N; Bosch, A; Cubedo, E; Farias, E; Fishel, M; Jones, JW; Kane, M; Leibovitch, B; Pereira, L; Pierzchalski, K; Waxman, S; Yu, J; Zelent, A | 1 |
| Chamberlin, R; Chen, PL; Lau, J; Lee, WH; Qiu, XL; Wu, G; Zhou, L; Zhu, J | 1 |
| Batlle, A; Battah, S; Casas, A; Di Venosa, G; Dobbin, P; Fukuda, H; MacRobert, AJ; Rodriguez, L | 1 |
| Egleston, BL; Golemis, EA; Izumchenko, E; Klein-Szanto, AJ; Singh, MK; Wolfson, M | 1 |
| Forinash, KD; Lawrence, NJ; Martin, MP; Patel, RA; Pireddu, R; Schönbrunn, E; Sebti, SM; Sun, N; Sun, Y | 1 |
| Alley, MC; Bibby, MC; Bradshaw, TD; Cooper, PA; Donohue, S; Double, JA; Fichtner, I; Sausville, EA; Stevens, MF; Stinson, SF; Tomaszewjski, JE | 1 |
| Brugge, JS; Daley, GQ; Koh, EY; Leder, P; Lu, Y; Martin, SS; Michelman, M; Pinkas, J; Reginato, MJ; Ridgeway, AG | 1 |
| Bai, R; Dettin, LE; Glazer, RI; Kopelovich, L; Kopleovich, L; Kozikowski, AP; Russell, RG; Wei, ZL; Yin, Y | 1 |
| Kumar, P; McEwan, AJ; McQuarrie, SA; Wiebe, LI; Zhou, A | 1 |
| Bryan, GT; Croft, WA; Wang, CY | 1 |
| Bryan, GT; Ertürk, E; Swaminathan, S | 1 |
| Mroczkowski, Z; Rockwell, S; Rupp, WD | 1 |
| Baruchel, S; Batist, G; Farah, R; Jamali, M; Wang, T | 1 |
| Batist, G; Carystinos, GD; Chen, X | 1 |
| Fujishita, T; Kobayashi, M; Mizushima, Y; Oosaki, R; Sassa, K | 1 |
| Koeffler, HP; Mehta, RG; Patel, MK; Williamson, E | 1 |
| Beauchamp, BK; Ding, I; Fenton, BM; Okunieff, P; Paoni, SF | 1 |
| Bruwiere, H; Dillen, L; Floren, W; Janicot, M; Janssen, B; Moelans, P; Sanz, G; van der Leede, BJ; van Dun, J; Van Ginckel, R; Van Heusden, J; Van Hove, C; Venet, M; Willemsens, G; Wouters, W | 1 |
| Rockwell, S | 1 |
| Dixon, B; Furr, BJ; Jordan, VC; Prestwich, G | 1 |
| Joss, U; Schieweck, K; Schmidt-Ruppin, KH | 1 |
| Müller, MR; Twentyman, PR; Wright, KA | 1 |
| Coley, HM; Twentyman, PR; Workman, P | 1 |
| Ip, MM; Schenkel, L; Sylvester, PW | 1 |
| Bryan, GT; Cohen, SM; Ertürk, E | 2 |
| Atassi, SA; Bryan, GT; Cohen, SM; Ertürk, E; Price, JM; Yoshida, O | 1 |
| Van Belle, H | 1 |
| Bryan, GT; Cohen, SM; Ertürk, E; Price, JM | 1 |
| Bryan, GT; Cohen, SM; Crovetti, AJ; Ertürk, E; Morris, JE; Price, JM; Von Esch, AM | 1 |
| Gabryel, P; Kasprzak, K; Malejka, D | 1 |
1 review(s) available for thiazoles and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Potential for selective modulation of glutathione in cancer chemotherapy.
Topics: Animals; Buthionine Sulfoximine; Cell Communication; Drug Resistance; Enzyme Inhibitors; Female; Gap Junctions; Glutamate-Cysteine Ligase; Glutathione; Humans; Mammary Neoplasms, Experimental; Neoplasms; Prodrugs; Pyroglutamate Hydrolase; Pyrrolidonecarboxylic Acid; Rats; Thiazoles; Thiazolidines | 1998 |
41 other study(ies) available for thiazoles and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Design and development of novel fasudil derivatives as potent antibreast cancer agent that improves intestinal flora and intestinal barrier function in rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Antineoplastic Agents; Breast Neoplasms; Colon; Drug Screening Assays, Antitumor; Female; Gastrointestinal Microbiome; Humans; Lipid Peroxidation; Mammary Neoplasms, Experimental; MCF-7 Cells; Rats, Sprague-Dawley; rho-Associated Kinases; Thiazoles | 2021 |
Tumor-targeting peptide functionalized PEG-PLA micelles for efficient drug delivery.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Survival; Coumarins; Drug Delivery Systems; Drug Liberation; Female; Humans; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice, Inbred ICR; Micelles; Paclitaxel; Peptides; Polyethylene Glycols; Spheroids, Cellular; Thiazoles; Tumor Burden | 2020 |
Fatostatin in Combination with Tamoxifen Induces Synergistic Inhibition in ER-Positive Breast Cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Injections, Intraperitoneal; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Pyridines; Receptors, Estrogen; Structure-Activity Relationship; Tamoxifen; Thiazoles | 2020 |
Analgesics promote welfare and sustain tumour growth in orthotopic 4T1 and B16 mouse cancer models.
Topics: Analgesics; Animal Welfare; Animals; Breast Neoplasms; Buprenorphine; Cell Line, Tumor; Disease Models, Animal; Female; Lung Neoplasms; Mammary Neoplasms, Experimental; Melanoma, Experimental; Meloxicam; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Metastasis; Pain; Thiazines; Thiazoles; Xenograft Model Antitumor Assays | 2018 |
Mouse ER+/PIK3CA
Topics: Aniline Compounds; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; BH3 Interacting Domain Death Agonist Protein; Cell Line, Tumor; Class I Phosphatidylinositol 3-Kinases; Cocarcinogenesis; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Estradiol; Estrogen Receptor alpha; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Gene Knock-In Techniques; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Mutation, Missense; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Neuropeptides; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Sulfonamides; Thiazoles | 2019 |
Dasatinib inhibits mammary tumour development in a genetically engineered mouse model.
Topics: Administration, Oral; Animals; Antineoplastic Agents; beta Catenin; Breast Neoplasms; Cadherins; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dasatinib; Dose-Response Relationship, Drug; Drug Administration Schedule; Enhancer Elements, Genetic; Female; Gene Expression Regulation, Neoplastic; Genes, erbB-2; Integrases; Lactoglobulins; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Neoplasm Invasiveness; Protein Kinase Inhibitors; PTEN Phosphohydrolase; Pyrimidines; Signal Transduction; src-Family Kinases; Thiazoles; Time Factors | 2013 |
PPARδ induces estrogen receptor-positive mammary neoplasia through an inflammatory and metabolic phenotype linked to mTOR activation.
Topics: Animals; Carcinogenesis; Carcinoma, Ductal; Epithelium; Female; Gene Expression; Genes, erbB-2; Inflammation; Inflammatory Breast Neoplasms; Mammary Neoplasms, Experimental; Metabolomics; Mice; Mice, Transgenic; Phenotype; PPAR delta; Proto-Oncogene Proteins c-akt; Receptors, Estrogen; Receptors, Progesterone; Thiazoles; TOR Serine-Threonine Kinases | 2013 |
Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal.
Topics: Animals; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Disease Progression; Disease-Free Survival; Endothelial Cells; Erythropoietin; Female; Gene Expression Regulation; Humans; Hypoxia; Mammary Neoplasms, Experimental; Mice; Neoplasm Transplantation; Neoplastic Stem Cells; Recurrence; Signal Transduction; Tetrazolium Salts; Thiazoles; Time Factors | 2014 |
PKA signaling drives mammary tumorigenesis through Src.
Topics: Androstadienes; Animals; Cell Line; Cell Proliferation; Cell Transformation, Neoplastic; Cyclic AMP-Dependent Protein Kinase RIalpha Subunit; Dasatinib; Epithelial Cells; Female; Humans; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Phosphorylation; Pyrimidines; Signal Transduction; src-Family Kinases; Thiazoles; Wortmannin | 2015 |
Modulatory effects of meloxicam on cardiotoxicity and antitumor activity of doxorubicin in mice.
Topics: Animals; Antibiotics, Antineoplastic; Caspase 3; Catalase; Cyclooxygenase 2 Inhibitors; Dinoprostone; Doxorubicin; Female; Glutathione; Glutathione Peroxidase; Heart Diseases; L-Lactate Dehydrogenase; Lipid Peroxidation; Mammary Neoplasms, Experimental; Meloxicam; Mice; Myocardium; Organ Size; Superoxide Dismutase; Thiazines; Thiazoles | 2014 |
PI3K-p110α mediates resistance to HER2-targeted therapy in HER2+, PTEN-deficient breast cancers.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Class I Phosphatidylinositol 3-Kinases; Drug Resistance, Neoplasm; Female; Humans; Lapatinib; Mammary Neoplasms, Experimental; Mice, Knockout; Molecular Targeted Therapy; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Quinazolines; Receptor, ErbB-2; Signal Transduction; Thiazoles; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |
Blocking the PAH2 domain of Sin3A inhibits tumorigenesis and confers retinoid sensitivity in triple negative breast cancer.
Topics: Animals; Antineoplastic Agents; Benzoates; Carcinogenesis; Cell Line, Tumor; Female; Humans; Indoles; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Receptors, Retinoic Acid; Repressor Proteins; Sin3 Histone Deacetylase and Corepressor Complex; Tetrahydronaphthalenes; Thiazoles; Triple Negative Breast Neoplasms | 2016 |
Small molecule targeting the Hec1/Nek2 mitotic pathway suppresses tumor cell growth in culture and in animal.
Topics: Animals; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Cell Proliferation; Cytoskeletal Proteins; Female; Humans; Indoles; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mitosis; Neoplasm Transplantation; NIMA-Related Kinases; Nuclear Proteins; Protein Serine-Threonine Kinases; Signal Transduction; Thiazoles; Transplantation, Heterologous; Valerates | 2008 |
Sustained and efficient porphyrin generation in vivo using dendrimer conjugates of 5-ALA for photodynamic therapy.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Cell Line, Tumor; Cell Survival; Coloring Agents; Dendrimers; Dose-Response Relationship, Drug; Injections, Subcutaneous; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Molecular Structure; Molecular Weight; Photochemotherapy; Photosensitizing Agents; Porphyrins; Protoporphyrins; Structure-Activity Relationship; Tetrazolium Salts; Thiazoles; Time Factors; Xenograft Model Antitumor Assays | 2009 |
Enhanced genetic instability and dasatinib sensitivity in mammary tumor cells lacking NEDD9.
Topics: Adaptor Proteins, Signal Transducing; Animals; Aurora Kinases; Blotting, Western; Cell Adhesion; Cell Cycle; Cell Movement; Cell Proliferation; Dasatinib; Embryo, Mammalian; Female; Fibroblasts; Flow Cytometry; Fluorescent Antibody Technique; Lung Neoplasms; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mammary Tumor Virus, Mouse; Mice; Mice, SCID; NIH 3T3 Cells; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; Pyrimidines; src-Family Kinases; Thiazoles; Xenograft Model Antitumor Assays | 2010 |
RKI-1447 is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancer.
Topics: Animals; Antineoplastic Agents; Binding Sites; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Crystallography, X-Ray; Cytoskeleton; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Models, Molecular; Molecular Structure; Neoplasm Invasiveness; NIH 3T3 Cells; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; rho-Associated Kinases; Substrate Specificity; Thiazoles; Tumor Burden; Urea | 2012 |
Preclinical evaluation of amino acid prodrugs of novel antitumor 2-(4-amino-3-methylphenyl)benzothiazoles.
Topics: Amino Acids; Aniline Compounds; Animals; Antineoplastic Agents; Benzothiazoles; Blotting, Western; Cell Division; Cytochrome P-450 CYP1A1; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Humans; Male; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Ovarian Neoplasms; Prodrugs; Rats; Rats, Sprague-Dawley; Thiazoles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2002 |
A cytoskeleton-based functional genetic screen identifies Bcl-xL as an enhancer of metastasis, but not primary tumor growth.
Topics: Animals; bcl-X Protein; Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cytoskeleton; Genetic Techniques; Genetic Vectors; Humans; Mammary Neoplasms, Experimental; MAP Kinase Kinase 1; Mice; Mitogen-Activated Protein Kinase Kinases; Neoplasm Metastasis; Proto-Oncogene Proteins c-bcl-2; Thiazoles; Thiazolidines | 2004 |
Peroxisome proliferator-activated receptor delta and gamma agonists differentially alter tumor differentiation and progression during mammary carcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Carcinoma, Adenosquamous; Carcinoma, Ductal; Carcinoma, Squamous Cell; Cell Differentiation; Disease Progression; Female; Gene Expression Profiling; Mammary Neoplasms, Experimental; Mice; Oxazoles; PPAR delta; PPAR gamma; Thiazoles; Tyrosine | 2005 |
[131I]Iodoazomycin arabinoside for low-dose-rate isotope radiotherapy: radiolabeling, stability, long-term whole-body clearance and radiation dosimetry estimates in mice.
Topics: Animals; Cell Hypoxia; Cell Proliferation; Female; Humans; Iodine Radioisotopes; Mammary Neoplasms, Experimental; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Nitroimidazoles; Radioimmunotherapy; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Tetrazolium Salts; Thiazoles; Tissue Distribution; Tumor Cells, Cultured | 2005 |
Tumor production in germ-free rats fed 5-nitrofurans.
Topics: Animals; Biotransformation; Carcinogens; FANFT; Female; Germ-Free Life; Intestines; Mammary Neoplasms, Experimental; Neoplasms, Experimental; Nitrofurans; Nitrofurantoin; Rats; Rats, Inbred Strains; Thiazoles | 1984 |
Mutagenicity, carcinogenicity, distribution, and nitroreduction of 4-(5-nitro-2-furyl)thiazole in the rat.
Topics: Animals; Carcinogens; Chromatography, High Pressure Liquid; Diet; FANFT; Feces; Female; Gas Chromatography-Mass Spectrometry; Liver Neoplasms; Mammary Neoplasms, Experimental; Mutagens; Nitrofurans; Rats; Salmonella typhimurium; Stomach Neoplasms; Thiazoles; Tissue Distribution | 1981 |
Evaluation of 2-amino-5-nitrothiazole as a hypoxic cell radiosensitizer.
Topics: Animals; Cells, Cultured; Drug Evaluation; Escherichia coli; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Radiation-Sensitizing Agents; Thiazoles | 1982 |
In vivo selective modulation of tissue glutathione in a rat mammary carcinoma model.
Topics: Animals; Antimetabolites, Antineoplastic; Bone Marrow; Buthionine Sulfoximine; Drug Synergism; Female; Glutathione; Kidney; Liver; Mammary Neoplasms, Experimental; Methionine Sulfoximine; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred F344; Thiazoles; Thiazolidines; Tumor Cells, Cultured | 1995 |
Therapeutic effect of clarithromycin on a transplanted tumor in rats.
Topics: Adenocarcinoma; Animals; Chromium Radioisotopes; Clarithromycin; Collagenases; Coloring Agents; Cytotoxicity, Immunologic; Humans; Interleukin-6; Male; Mammary Neoplasms, Experimental; Matrix Metalloproteinase 9; Neoplasm Transplantation; Rats; Rats, Inbred F344; Spleen; Tetrazolium Salts; Thiazoles; Transforming Growth Factor beta; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1999 |
A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Antineoplastic Agents; Carcinogens; Chromans; Estradiol; Female; Ligands; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Organ Culture Techniques; Precancerous Conditions; Progesterone; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Retinoic Acid Receptor gamma; Retinoid X Receptors; Retinoids; Thiazoles; Thiazolidinediones; Transcription Factors; Tretinoin; Troglitazone | 2000 |
Characterization of the effects of antiangiogenic agents on tumor pathophysiology.
Topics: Angiogenesis Inhibitors; Animals; Celecoxib; Cell Hypoxia; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Etanidazole; Hydrocarbons, Fluorinated; Image Processing, Computer-Assisted; Immunohistochemistry; Isoenzymes; Mammary Neoplasms, Experimental; Meloxicam; Mice; Mice, Inbred C3H; Models, Animal; Neovascularization, Pathologic; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Thiazines; Thiazoles | 2001 |
Inhibition of all-TRANS-retinoic acid metabolism by R116010 induces antitumour activity.
Topics: Animals; Antineoplastic Agents; Benzothiazoles; Breast Neoplasms; Cell Division; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Female; Humans; Imidazoles; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Mixed Function Oxygenases; Retinoic Acid 4-Hydroxylase; Reverse Transcriptase Polymerase Chain Reaction; Thiazoles; Tretinoin; Tumor Cells, Cultured | 2002 |
Cytotoxic and radiosensitizing effects of hypoxic cell sensitizers on EMT6 mouse mammary tumour cells in vivo and in vitro.
Topics: Animals; Cell Survival; In Vitro Techniques; Lethal Dose 50; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nitroimidazoles; Oxygen; Pyrroles; Radiation-Sensitizing Agents; Thiazoles | 1978 |
The mode of action of the antitumour agent GP 48,989 in the rat.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Castration; Female; Luteinizing Hormone; Mammary Neoplasms, Experimental; Neoplasm Transplantation; Ovary; Random Allocation; Rats; Receptors, Estrogen; Tamoxifen; Thiazoles; Time Factors; Transplantation, Homologous; Uterus | 1979 |
Regression of "hormone-independent" DMBA-induced mammary carcinomas in response to GP 48989 and its effects on hormone receptors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenofibroma; Animals; Benz(a)Anthracenes; Carcinoma; Castration; Cytoplasm; Estradiol; Female; Mammary Neoplasms, Experimental; Rats; Receptors, Estrogen; Thiazoles; Thiazolidines | 1976 |
Differential properties of cisplatin and tetraplatin with respect to cytotoxicity and perturbation of cellular glutathione levels.
Topics: Animals; Antineoplastic Agents; Cell Line; Cisplatin; Coloring Agents; Drug Resistance; Drug Screening Assays, Antitumor; Glutathione; Mammary Neoplasms, Experimental; Mice; Organoplatinum Compounds; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1991 |
Identification of anthracyclines and related agents that retain preferential activity over adriamycin in multidrug-resistant cell lines, and further resistance modification by verapamil and cyclosporin A.
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Small Cell; Cell Line; Coloring Agents; Cyclosporins; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Female; Humans; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Verapamil | 1989 |
Antitumor efficacy in rats of CGP 19984, a thiazolidinedione derivative that inhibits luteinizing hormone secretion.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Castration; Corticosterone; Female; Luteinizing Hormone; Male; Mammary Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Prolactin; Prostatic Neoplasms; Rats; Rats, Inbred F344; Testosterone; Thiazoles; Thiazolidines | 1986 |
Carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl] acetamide in female rats.
Topics: Acetamides; Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adenofibroma; Animals; Carcinogens; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemical Phenomena; Chemistry; Female; Fibroma; Fibrosarcoma; Intestinal Neoplasms; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymphoma, Non-Hodgkin; Mammary Neoplasms, Experimental; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Nitrofurans; Rats; Salivary Gland Neoplasms; Skin Neoplasms; Splenic Neoplasms; Thiazoles; Time Factors; Transplantation, Homologous | 1970 |
Carcinogenicity of formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolyl]-hydrazide in Swiss mice.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Animals; Body Weight; Carcinogens; Carcinoma, Squamous Cell; Diet; Female; Formates; Hydrazines; Leukemia, Experimental; Liver Neoplasms; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Neoplasm Metastasis; Neoplasms, Experimental; Nitrofurans; Skin Neoplasms; Stomach Neoplasms; Thiazoles; Uterine Neoplasms | 1970 |
Comparative urinary and gallbladder carcinogenicity of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide and N-(4-(5-nitro-2-furyl)-2-thiazolyl)acetamide in the dog.
Topics: Acetamides; Adenocarcinoma; Adenocarcinoma, Scirrhous; Adenofibroma; Animals; Carcinogens; Carcinoma, Transitional Cell; Dogs; Female; Formamides; Gallbladder; Gallbladder Neoplasms; Kidney Neoplasms; Mammary Neoplasms, Experimental; Neoplasms, Experimental; Nitrofurans; Thiazoles; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms; Urogenital System | 1970 |
Kinetics and inhibition of alkaline phosphatases from canine tissues.
Topics: Alkaline Phosphatase; Animals; Anthelmintics; Autoanalysis; Bone and Bones; Dogs; Escherichia coli; Ethanolamines; Female; Hydrogen-Ion Concentration; Imidazoles; Intestines; Kidney; Kinetics; Liver; Magnesium; Mammary Neoplasms, Experimental; Nitrophenols; Organ Specificity; Osmolar Concentration; Placenta; Pregnancy; Structure-Activity Relationship; Thiazoles | 1972 |
Comparative carcinogenicity in the rat of 2-hydrazinothiazoles with nitrofuryl, nitrophenyl, or aminophenyl substituents in the 4-position.
Topics: Adenocarcinoma; Adenofibroma; Animals; Body Weight; Carcinogens; Chemical Phenomena; Chemistry; Diet; Female; Hydrazines; Lung Neoplasms; Lymphoma, Non-Hodgkin; Mammary Neoplasms, Experimental; Neoplasm Metastasis; Neoplasms, Experimental; Nitrobenzenes; Nitrofurans; Rats; Salivary Gland Neoplasms; Splenic Neoplasms; Thiazoles | 1970 |
Comparative carcinogenicity of formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolyl]hydrazide and related chemicals in the rat.
Topics: Animals; Carcinogens; Female; Formates; Furans; Hydrazines; Kidney Neoplasms; Liver Neoplasms; Male; Mammary Neoplasms, Experimental; Mice; Neoplasms, Experimental; Nitrofurans; Rats; Semicarbazides; Thiazoles | 1971 |
Autoradiographic evaluation of the distribution of N,N'-bis(thiazole)-2,7-fluorene-disulphonamide-35S in organs of rats.
Topics: Animals; Autoradiography; Carcinoma 256, Walker; Fluorenes; In Vitro Techniques; Kidney; Liver; Male; Mammary Neoplasms, Experimental; Rats; Spleen; Sulfonamides; Sulfur Isotopes; Thiazoles | 1965 |